The Weight-Loss Drug Revolution, Part 1: Why ...

Two extraordinary trends are happening in the United States simultaneously. One is that alcohol consumption is declining precipitously. The share of Americans who drink has hit a record low since Gallup started tracking it in the 1930s. In 2004, fewer than 30 percent of Americans ...  Afficher plus

There’s no doubt that reading is in decline. But what is that decline doing to the way we think? Derek talks with The Atlantic's Rose Horowitch about why Americans are reading fewer books than ever and struggling more with complex texts and what that means for education, work, po ...  Afficher plus

What started as a story about Hollywood waistlines has become a global phenomenon. Weight loss drugs are becoming more and more mainstream a few years after making their dramatic debut. On this weekend episode of Reuters World News, our health reporters weigh in on the impact of ...  Afficher plus

A new group of drugs for type 2 diabetes and obesity have shown to be more effective for weight loss than any previous medications. Some medications like Ozempic and Wegovy have surged in popularity thanks in part to celebrity use. But who should be taking them? And are they safe ...  Afficher plus

Pharmaceutical companies and insurance providers are at odds over a new class of drugs that have proven quite effective at helping people living with obesity lose weight. Bloomberg’s Robert Langreth and Emma Court join this episode to share their reporting on recent advancements ...  Afficher plus

Eli Lilly and Novo Nordisk can’t keep up with demand for their weight loss medications. In this Viewsroom podcast, Breakingviews columnists discuss the hype among celebrities, the different approaches to prescribing them in the US and Europe, and how they can reshape the world. V ...  Afficher plus